The potencies and intrinsic activities of agonists in activating clone
d alpha(1)-adrenergic receptor (AR) subtypes were compared. The hamste
r alpha(1B)-, bovine alpha(1C)-, or rat alpha(1A/D)-ARs were expressed
at high levels in human embryonic kidney 293 cells. Catecholamines an
d phenylethylamines, but not lower efficacy agonists, were more potent
in inhibiting radioligand binding to the expressed alpha(1A/D) subtyp
e than to the alpha(1B) or alpha(1C) subtypes; this selectivity remain
ed in the presence of different buffers, nucleotides, and cations. Act
ivation of all three subtypes caused substantial increases in [H-3]ino
sitol phosphate formation in cells grown in 96-well plates. Pretreatme
nt with phenoxybenzamine decreased maximal responses to norepinephrine
(NE) with only smalt decreases in apparent potency, suggesting simila
r small receptor reserves for all three subtypes. The catecholamines N
E, epinephrine, and 6-fluoro-NE were full agonists with similar potenc
ies at the three subtypes; alpha-methyl-NE was also a full agonist but
was about 20-fold less potent at alpha(1B)-ARs than at alpha(1C)- or
alpha(1A/D)-ARs. Phenylephrine had similar potencies at all three subt
ypes but gave a submaximal response at alpha(1B)-ARs. Methoxamine was
a full agonist at alpha(1C)- and alpha(1A/D)-ARs, with about 20-fold g
reater potency at the alpha(1C) subtype, but showed lower intrinsic ac
tivity at alpha(1B)-ARs. A number of imidazolines, amide-phrine, and S
KF 89748 had substantial intrinsic activity at alpha(1C)-ARs but littl
e or no intrinsic activity at the other two subtypes. We conclude that
the potencies of many agonists in competing for radioligand binding s
ites are related to their potencies in activating functional responses
but that this relationship is not the same for all subtypes. NE and e
pinephrine activate all three cloned alpha(1)-AR subtypes With similar
potencies and intrinsic activities, but many widely used agonists sho
w significant selectivity for different alpha(1)-AR subtypes.